Sangya Agarwal

Amgen (United States) — United States

Medicine · Health Sciences

13h-index1.4kcitations73works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(55), CRISPR and Genetic Engineering(13), T-cell and B-cell Immunology(6), COVID-19 Clinical Research Studies(5), SARS-CoV-2 and COVID-19 Research(4)

Publications73 total

Genetic elements promote retention of extrachromosomal DNA in cancer cells
Nature·2025· 5 citedOpen Access
Genetic elements promote retention of extrachromosomal DNA in cancer cells
2025Open Access
Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer
Cell Reports Medicine·2025· 2 citedOpen Access
<div> Counterparty Risk in <span>MDB Exposure </span><span>Exchange Agreements</span></div>
SSRN Electronic Journal·2025Open Access
Financial Regulation and Capital Flows to EMDEs
SSRN Electronic Journal·2025Open Access
<div> Counterparty Risk in <span>MDB Exposure </span><span>Exchange Agreements</span></div>
SSRN Electronic Journal·2025Open Access
Ratings and Capital Constraints on IBRD and IDA 
SSRN Electronic Journal·2025Open Access
Implications of the CAF Panel Report for IBRD and IDA
SSRN Electronic Journal·2025Open Access
237 Enhancing mesothelin-directed CAR T cell therapy for unresectable or metastatic pancreatic adenocarcinoma
Regular and Young Investigator Award Abstracts·2024· 1 citedOpen Access
Evaluation of malnutrition’s influence on lung cancer patients undergoing lung resection
Clinical Nutrition ESPEN·2024
Data from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Figure 1 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Figure 1 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Tables from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Figure 2 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Data from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Tables from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Figure 2 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
Cancer Immunology Research·2024· 2 cited
Improving Treatment for Blood Cancers
2024Open Access
page 1 of 4Next →

Frequent Co-authors

Carl H. June(36), Nathan Singh(23), Saar Gill(23), Shunichiro Kuramitsu(22), Charly R. Good(21), Marco Ruella(20), Shelley L. Berger(20), Pranali Ravikumar(20), Yong Gu Lee(16), Olga Shestova(16), Katharina E. Hayer(16), Seok Jae Hong(16), Xueqing Maggie Lu(16), Raymone Pajarillo(16), Elena J. Orlando(16), Karen Thudium Mueller(16), Ophir Shalem(16), Matthew D. Weitzman(16), Noelle V. Frey(16), Shannon L. Maude(16)